I would be surprised if the trial finished prematurely based on the relatively rare incidence of such examples. I think it would be awesome and welcomed, but unlikely.
I have spent time with retts patients, and I would consider their condition worthy of fast tracked trials. But, I'm not a part of the FDA or the ethics committee. Time will tell. If they dont fast track the trial, well I turn out to be right. In the unlikely event they do end the trial early, I'll be very very happy to admit I was wrong.
retts syndrome, page-29
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $18.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.65 | 1127 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |